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Abstract The aim of this study was to determine if aging or
dietary restriction (DR) alters activation-induced cell death,
which is known to regulate cell proliferation and eliminate the
high number of activated cells during an immune response.
Splenic T cells were isolated from young (4^6 months) and old
(25^26 months) Fischer 344 rats that had free access to food, ad
libitum (AL), and from dietary-restricted (DR) old (25^26
months) rats that beginning at 6 weeks of age were fed 60% (40%
food-restricted) of the diet consume by the AL rats. T cells were
incubated with anti-CD3 antibody, or staphylococcal enterotoxin
B (primary stimulus) for 72^96 h, followed by restimulation with
anti-CD3 (secondary stimulus) for 72 h. Activation-induced
apoptosis was assessed by DNA fragmentation and the expres-
sion of Fas/CD95 receptor and Fas ligand (Fas-L) was measured
by flow cytometry. We found that the amount of DNA
fragmentation was significantly (P6 0.05) higher in the stimu-
lated and restimulated T cells from AL old rats and DR old rats
compared to young rats. The increase in DNA fragmentation
with age was paralleled by an increase in the proportion of the
cells expressing Fas and Fas-L. However, DR had no significant
effect on the age-related increase in DNA fragmentation or the
expression of Fas or Fas-L. We also measured the levels of Bcl-2
and Bax protein and found that the level of Bcl-2 decreased and
Bax increased with age and that DR had no effect on the age-
related changes in the level of Bcl-2 or Bax protein. These results
demonstrate that aging but not DR alters activation-induced
apoptosis in rat T cells. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Apoptotic cell death plays a key role in the maintenance of
homeostasis in various physiological systems including the
immune system (reviewed in [1]). Stimulation of T cells with
activating agents such as concanavalin A, PHA (phytohemag-
glutinin), mitogenic antibody (anti-CD3), or superantigen,
staphylococcal enterotoxin B (SEB), results in a strong pro-
liferative response that usually leads to the expansion of cells
and the expression of cytokines (e.g. IL-2). If the responding
cells are allowed to revert to a resting phenotype and are
subsequently restimulated, substantial amounts of cytokines
are produced. Nevertheless, instead of entering another round
of proliferation, the majority of the restimulated cells rapidly
undergo activation-induced cell death (AICD) (reviewed in
[2,3]). This process is of physiological importance because
the presence of too many activated cells with di¡erent specif-
icities might trigger excessive secondary immune responses
leading to symptoms similar to autoimmune disorders and
toxic shock [2,3].
Activation-induced apoptosis is mediated by Fas (CD95)
receptor, a 48 kDa surface glycoprotein belonging to the tu-
mor necrosis factor/nerve growth factor receptor family. In-
teraction of Fas with its ligand Fas/CD95 ligand (Fas-L) trig-
gers a series of events leading to DNA fragmentation and cell
disintegration [4,5]. In addition, gene products of some mem-
bers of the Bcl-2 family of protooncogenes (e.g. Bcl-2 and Bcl-
xL) have apoptosis-inhibiting activity whereas other members
(e.g. Bax and Bad) have been shown to promote apoptosis
(reviewed in [6,7]). The Bcl-2 family members can bind to each
other in various pairwise combinations (e.g. homodimers of
Bcl-2:Bcl-2 or heterodimers like Bcl-2:Bax), and form ion-
conducting channels in the mitochondria membrane [6,7].
How Bcl-2 family members function to promote or inhibit
apoptosis is uncertain. The leading theory is that the anti-ap-
optotic Bcl-2-like proteins inhibit caspase activation either by
binding directly to a protein called Apaf-1 (apoptotic promot-
ing activating factor-1) or by preventing the release of cyto-
chrome c from mitochondria, or both [6,7].
Research over the past three decades has shown that dietary
restriction (DR) (i.e. 40% restriction in caloric intake) dramat-
ically extends the life span and reduces the rate of occurrence
of numerous physiological dysfunctions in laboratory rodents
(reviewed in [8,9]). In addition, DR has been found to delay
the incidence of most age-related diseases [8,9] and retard a
wide variety of age-sensitive immunological parameters (re-
viewed in [10,11]). Our laboratory has previously shown that
the induction of T cell proliferation and IL-2 expression is
diminished with age in rat T cells and that DR attenuated
the changes [10,11]. More recently, we found that the induc-
tion of Ras/MAPK (mitogen-activated protein kinase) activa-
tion decreased with age [12] and that DR reduced the age-
related decline in the activation of MAPK but not Ras activ-
ity [13]. Although the e¡ect of DR on aging immune system
has been investigated by a number of laboratories including
our laboratory [11], little is known about the impact of aging
or DR on activation-induced apoptosis. Therefore, the objec-
tive of the present study was to determine if aging or DR
a¡ects AICD in T cells. We hypothesized that AICD increases
with age and that DR might attenuate the changes. Our re-
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sults show that the activation-induced DNA fragmentation,
Fas, Fas-L, Bax, Bcl-2 changes with age in T cells. However,
DR had no signi¢cant e¡ect on the age-related changes in the
apoptotic parameters that were measured.
2. Materials and methods
2.1. Animals
Male Fischer 344 rats (speci¢c pathogen-free) were obtained at
3 weeks of age from Harlan Sprague-Dawley (Indianapolis, IN,
USA). The rats were caged individually in a barrier facility with a
12 h light/dark cycle and were fed a diet as we previously described
[14]. At 6 weeks of age, the rats were randomly assigned to two
groups. The control group was given free access to the diet and the
restricted group received 60% of the diet consumed by the control rats
[14]. Three groups of rats were used in these experiments: young
(6 month) and old (24 month) rats that were fed ad libitum (AL)
and old (24 month) rats fed a restricted diet (DR), 60% of calories
consumed by AL rats.
2.2. Cell preparation and activation-induced apoptosis in vitro
Splenic T cells were obtained from rats as we previously described
[15]. The cells were resuspended in culture medium, plated in a tissue
culture £ask, and incubated in the presence or absence of stimulating
agent (described below).
Activation-induced apoptosis was performed as described by Rad-
vanyi et al. [16]. The puri¢ed T cells (2 million cells/ml) were stimu-
lated with mitogenic antibody (anti-CD3) or SEB (10 Wg/ml) plus
antigen presenting cells, irradiated adherent cells (B cells and macro-
phages, 1:1 ratio). After 72^96 h of anti-CD3 or SEB stimulation
(primary stimulus), the cells were then harvested, re-plated in a tissue
culture £ask coated with anti-CD3 antibody (secondary stimulus).
Cultured cells were supplemented with exogenous IL-2 (50 U/ml)
and after 72 h of incubation, cells were harvested and the occurrence
of the activation-induced apoptosis was measured.
2.3. DNA fragmentation analysis
Quantitation of DNA fragmentation was performed by determina-
tion of fractional solubilized DNA by diphenylamine (DPA) dye and
spectro£uorimetric assay, as described by Duke and Cohen [17]. The
DNA was precipitated with 0.5 ml of 25% trichloroacetic acid and
was incubated for 15 min at 90‡C to hydrolyze DNA. Each DNA
sample was then supplemented with 160 Wl of DPA reagents (Sigma),
and color was allowed to develop for 4 h at 37‡C. 200 Wl of colored
solution was transferred to a well of a 96-well £at-bottom enzyme-
linked immunosorbent assay plate and the optical density was deter-
mined by a spectrophotometer at a wavelength of 620 nm. Percentage
DNA fragmentation was calculated as the ratio of DPA £uorescence
in the supernatant divided by the total £uorescence in the supernatant
plus the pellet multiplied by 100 [17].
Qualitative DNA fragmentation analysis was performed by lysing
the cells in lysis bu¡er, and the fragmented DNA was extracted fol-
lowing the procedure described by Herrman et al. [18]. Fragmented
DNA with the loading bu¡er was electrophoresed on 1.2% agarose gel
at 2 V/cm for 15 h. The DNA in the gel was visualized under UV after
staining with 5 mg/ml ethidium bromide.
2.4. Flow cytometric analysis of Fas and Fas-L
The proportion of the activated T cells expressing Fas and Fas-L
was assessed by £ow cytometry as previously described [19]. Brie£y, T
cells (1^2 million) were washed and resuspended in FACS bu¡er
(phosphate-bu¡ered saline with 5% fetal calf serum, and 0.1% sodium
azide). Cells were stained with optimal concentration (10 Wg/ml) of
FITC-anti-Fas antibody (PharMingen, San Diego, CA, USA). The
analysis of Fas-L expression was performed by incubating the cells
in permeabilized solution (0.33% saponin at 4‡C) for 60 min followed
by staining with FITC-anti-Fas-L antibody (PharMingen, San Diego,
CA, USA). An isotype-matched negative control was used to deter-
mine the background of £uorescence. Cells were incubated for 30 min
at 4‡C, washed twice with FACS bu¡er, and were analyzed with a
£ow cytometer (FACScan, Becton Dickinson). The samples were
gated using forward versus 90‡ light. For each test sample, 10 000
cells were analyzed and the results were expressed as percentage of
the gated cells.
2.5. Western blotting
The levels of Bcl-2 and Bax proteins in the activated T cells were
determined by immunoblotting as we previously described [12]. Pro-
tein samples (30 Wg) were electrophoresed on 10 or 12% SDS^polyac-
rylamide gel for 3 h at 30 mA. Separated proteins were transferred to
a nitrocellulose membrane and probed with an appropriate dilution of
the primary antibody for Bcl-2, Bax or actin (control). The immune
complex was detected using an enhanced chemoluminescence detec-
tion system (ECL) (Amersham, Arlington Heights, IL, USA).
2.6. Statistical analysis
The Mann^Whitney U test was used to make comparisons between
the two independent samples, young and old AL rats or young and
old DR rats. The Wilcoxon signed rank test was used to determine the
signi¢cant di¡erence between matched groups, i.e. AL old rats vs. DR
old rats.
Fig. 1. E¡ect of age and DR on activation-induced DNA fragmentation in T cells from rats. Splenic T cells were isolated from young (6
month) and old (24 month) rats fed AL or old rats fed a restricted diet (DR). Cells were stimulated with anti-CD3 or SEB for 72^96 h (pri-
mary stimulus) followed by restimulation with anti-CD3 (secondary stimulus). DNA fragmentation was assessed 72 h after restimulation and
the ratio of low to high molecular weight DNA was determined (left panel) and expressed as percentage as described in Section 2. Each point
represents the mean þ S.E.M. for data obtained from AL young (eight spleens) and old (six spleens) rats and from DR old (six spleens) rats.
*The values for AL and DR old rats were signi¢cantly di¡erent from the value for the AL young rats at P6 0.05. DNA gel electrophoresis
was used to detect DNA ladder formation (right panel). Splenic T cells pooled from three young and two old rats were incubated without stim-
ulatory agent (A) or stimulated and restimulated with anti-CD3 for 72 h (B). DNA extract was prepared and DNA ladder formation was de-
termined by gel electrophoresis as described in Section 2. Lanes 1 and 2, DNA isolated from unstimulated and restimulated T cells from AL
young rats, respectively. Lanes 3 and 4, DNA isolated from unstimulated and restimulated T cells from AL old rats, respectively.
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3. Results and discussion
It has been demonstrated that reactivation of T cells after a
short period of resting triggers the cells to undergo apoptosis.
This phenomenon, which is known as AICD, is believed to
limit cell proliferation and to eliminate the high number of
activated cells during an immune response (reviewed in [2,3]).
In the apoptotic cells, DNA is cleaved into oligonucleosomal
fragments [20^22], probably through the activation of an en-
dogenous endonuclease [23,24]. It has been demonstrated that
micrococcal nuclease-induced cleavage of DNA in isolated
nuclei causes ultrastructural changes similar to those seen in
apoptotic nuclei, and therefore DNA fragmentation may be
the trigger for such nuclear changes in apoptosis [21]. Immu-
nologic functions decrease with age [25,26] and DR has been
shown to reduce/retard the age-related decline in immune
function, e.g. mitogen-induced proliferation and IL-2 expres-
sion (reviewed in [10,11]). In view of the known age-related
decline in immune function and the bene¢cial e¡ect of DR on
immunosenescence and given the potential important role of
apoptosis in lymphocyte homeostasis, it was of interest to
determine whether aging or DR alters the events that regulate
activation-induced apoptosis in T cells. Fig. 1 shows that
DNA extracted from resting T cells from AL young or old
rats or DR old rats had a very low level of DNA fragmenta-
tion. However, the amount of fragmented DNA was increased
after stimulation with anti-CD3 or SEB (primary stimulus),
followed by restimulation with anti-CD3 (secondary stimu-
lus). For example, after primary and secondary stimulation
with anti-CD3, the percentage of fragmented DNA was 66%
and 45% higher for activated T cells isolated from AL old rats
and DR old rats, respectively, than for T cells isolated from
young rats. Although DNA fragmentation was approximately
12% lower in the activated T cells from DR old rats compared
to the activated T cells from AL old rats, this di¡erence was
not statistically signi¢cant. Our results demonstrate that re-
gardless of whether cells were stimulated with anti-CD3 or
SEB, the activation-induced DNA fragmentation was in-
creased with age and that DR had no signi¢cant e¡ect on
the age-related increase in activation-induced DNA fragmen-
tation. The activation-induced DNA fragmentation was also
con¢rmed by conventional DNA ladder analysis, which is
frequently used to assess apoptosis [18]. As shown in Fig. 1,
DNA ladder formation was undetectable in the unstimulated
Fig. 2. E¡ect of age and DR on activation-induced Fas and Fas-L expression. Splenic T cells from AL young and old rats and from DR old
rats were incubated with SEB for 96 h, followed by restimulation with anti-CD3 for 72 h. Cells were stained with anti-Fas or anti-Fas-L anti-
body and the percentages Fas positive cells (A) and Fas-L positive cells (B) were assessed by £ow cytometry as described in Section 2. Each
point represents the mean þ S.E.M. for data obtained from AL young (six spleens) and old (four spleens) rats and from DR old (four spleens)
rats. *The values for AL and DR old rats were signi¢cantly di¡erent from the value for the AL young rats at P6 0.05.
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cells from young and old rats. However, DNA ladder forma-
tion increased in T cells from both young and old rats that
were stimulated and restimulated with anti-CD3. The data in
Fig. 1 show that the DNA ladder formation was more intense
in the activated T cells from old rats than in the activated T
cells from young rats.
The mechanism by which activation-induced DNA frag-
mentation increases with age is yet to be determined. The
conventional understanding is that T cells can be induced in
vitro to up-regulate Fas and Fas-L when cells are subjected to
prolonged stimulation with mitogen or antigen [27^31]. Fas
surface protein is highly expressed on activated T cells, and it
has been suggested that it may play a crucial role in activa-
tion-induced apoptosis in T cells [4,5]. Fas-L is not expressed
on resting cells but increases in expression during T cell acti-
vation, and it can cross-link to Fas, leading to apoptosis [3^5].
In addition, an increase in Bax protein has been associated
with promotion of apoptosis and converse e¡ects occur when
the level of Bcl-2 protein increases [6,7]. To establish that the
increase in activation-induced DNA fragmentation that we
have observed with age was associated with an increase in
the proportion of the activated T cells expressing Fas or
Fas-L, we measured the percentage of Fas and Fas-L cells
in the activated T cells using £ow cytometry. Fig. 2 shows that
in unstimulated T cells the proportion of cells expressing Fas
and Fas-L was very low in T cells isolated from either AL
young and old rats or DR old rats. However, the proportion
of T cells expressing Fas and Fas-L increased after primary
(SEB) and secondary (anti-CD3) stimulation. The percentage
of Fas T cells was signi¢cantly (P6 0.05) higher in the acti-
vated T cells from AL old rats and DR old rats compared to
the activated T cells from young rats. The expression of Fas
surface protein was 62% and 88% higher in the activated T
cells from AL old and DR old rats, respectively, than acti-
vated T cells from young rats. Similarly, the expression of
Fas-L was 46% and 78% higher in the activated T cells
from AL old and DR old rats, respectively, than activated
T cells from young rats (Fig. 2). Although the proportion of
Fas and Fas-L cells was approximately 12^18% higher in
the activated T cells from DR old rats compared to AL old
rats, the di¡erence was not statistically signi¢cant.
Because Bcl-2 and Bax proteins have been implicated in the
regulation of apoptosis [1,4^7], we also measured the levels of
Bcl-2 and Bax proteins in the resting and activated T cells by
Western blot analysis using speci¢c antibodies that recognize
each protein or an antibody against actin as a control. Fig. 3
shows a representative Western blot of protein extracts iso-
lated from the cells after primary (SEB) and secondary (anti-
CD3) stimulation. A very low level of the Bcl-2 and Bax
proteins was detected in the unstimulated cells from AL
young and old rats and DR old rats. However, 72 h after
secondary stimulation the levels of Bcl-2 protein decreased
and Bax protein increased with age. For example, the Bcl-2
protein level was approximately 60% and 65% lower for the
activated T cells from AL old and DR old rats, respectively,
compared to the activated T cells from young rats. In con-
trast, Bax protein level was 62% and 75% higher for the acti-
vated T cells from AL old rats and DR old rats, respectively,
than the activated T cells from young rats (Fig. 3). Although
the level of Bcl-2 and Bax protein was slightly higher in the
DR old rats compared to the AL old rats, this di¡erence was
not statistically signi¢cant. Thus, our results for the ¢rst time
show that activation-induced apoptosis as assessed by DNA
fragmentation, Fas, Fas-L, Bcl-2, and Bax expression alters
with age and that DR had no signi¢cant e¡ect on the age-
related changes in the apoptotic parameters that were mea-
sured.
Our results are in agreement with recent studies showing
that activation-induced Fas/CD95 expression is increased
with age in T cells [32^37]. In addition, this study suggests
that activation-induced apoptosis in rat T cells is mediated
through the Fas/Fas-L signaling pathway. Our data also
show that activation-induced apoptosis changed with age
but not with DR. The lack of in£uence of DR on activa-
tion-induced apoptosis in rat T cells was somewhat unex-
pected in light of a study in mice that show the inducibility
of apoptosis by dexamethasone decreases with age and that
DR signi¢cantly reversed the age-related decline in apoptosis
[38]. The di¡erence between this study and our ¢ndings may
re£ect di¡erences in the experimental design, the assay system,
cell population analyzed and/or species of rodents studied.
For example, in the study reported by Reddy et al. [38], T
cells were stimulated only once with anti-CD3 for 24 h. Ap-
optosis was assessed by measuring the expression of annexin
V as an indicator of apoptosis. These di¡erences in experi-
mental design could contribute to the discrepancy between
this study and our results. A recent study has demonstrated
that aging accelerated and DR suppressed apoptosis-related
Fas expression in mice hepatocytes [39]. In addition, DR has
Fig. 3. E¡ect of age and DR on the levels of Bcl-2 and Bax pro-
teins in T cells from rats. Splenic T cells from AL young (A) and
old (B) rats and from DR old (C) rats were incubated without stim-
ulatory agent (panel 1) or with SEB for 96 h, followed by restimula-
tion with anti-CD3 for 72 h (panel 2). Bcl-2 and Bax protein levels
were determined by Western blot analysis as described in Section 2.
The blots were probed with anti-actin antibody as a control. The
bands corresponding to activation-induced Bcl-2 and Bax expression
were quanti¢ed by densitometry, and the data are presented in the
graph. Each point represents the mean þ S.D. for data obtained
from three experiments and each experiment was pooled from two
rats. *The values for AL and DR old rats were signi¢cantly di¡er-
ent from the value for the AL young rats at P6 0.05.
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been shown to enhance p53 expression but not increase apo-
ptosis in rat hepatocytes [40].
Apoptosis has been proposed to play an important role in
inhibiting tumor development by eliminating damaged and
generically transformed cells from tumor-susceptible tissues
[41^46]. Cancer cells die at a higher rate than normal cells,
suggesting that environmental modulators of apoptosis can
in£uence the rate of tumor growth. For example, DR reduces
cancer progression by stimulating apoptosis of precancerous
cells [47,48]. DR has also been shown to increase the sponta-
neous apoptotic rate and decrease cell proliferation rate in
mice hepatocytes [48]. The fact that in our study the apoptotic
parameters that were measured changed with age but not with
DR suggests that the in£uence of DR on activation-induced
proliferation and cell death can vary considerably from one
type of cell to another (e.g. normal cells vs. cancer cells). The
increased proliferation rate observed in cancerous cells is
often accompanied by a parallel increase in apoptosis
[49,50]. It has been suggested that this adaptive apoptotic
response may serve an important protective role in countering
aberrant hyperplasia [49^51]. Cellular homeostasis depends on
an integrated balance between cell proliferation and cell death
such that during normal cell turnover the rates of these two
processes are counterbalanced and equivalent [52,53]. The ho-
meostatic maintenance of cell proliferation and cell death may
also contribute to a critical defense mechanism in response to
endogenous and exogenous stressors. Future studies on the
molecular events that regulate AICD may help to elucidate
the role of diet and aging on cell proliferation and cell death.
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